Crescent Grove Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Crescent Grove Advisors’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Sell	1,441 -42	-3%	-$6.25K	0.02%	271
2026 Q1	$217K	Sell	1,483 -3,591	-71%	-$554K	0.02%	284
2025 Q4	$785K	Buy	5,074 +3,559	+235%	+$533K	0.07%	147
2025 Q3	$211K	Sell	1,515 -77	-5%	-$10.4K	0.02%	279
2025 Q2	$215K	Sell	1,592 -225	-12%	-$30.4K	0.02%	265
2025 Q1	$265K	Hold	1,817	–	–	0.03%	225
2024 Q4	$250K	Sell	1,817 -13	-0.7%	-$1.9K	0.02%	245
2024 Q3	$282K	Hold	1,830	–	–	0.03%	227
2024 Q2	$267K	Hold	1,830	–	–	0.03%	224
2024 Q1	$270K	Buy	+1,830	New	+$263K	0.03%	256
2023 Q4	–	Sell	-2,518	Closed	-$324K	–	298
2023 Q3	$324K	Buy	+2,518	New	+$334K	0.04%	215
2023 Q2	–	Sell	-2,557	Closed	-$331K	–	309
2023 Q1	$331K	Sell	2,557 -97	-4%	-$12.7K	0.04%	221
2022 Q4	$361K	Buy	2,654 +488	+23%	+$64.7K	0.04%	211
2022 Q3	$262K	Buy	2,166 +377	+21%	+$48.6K	0.03%	222
2022 Q2	$229K	Sell	1,789 -1,149	-39%	-$151K	0.02%	234
2022 Q1	$402K	Buy	+2,938	New	+$389K	0.04%	188
2021 Q4	–	Sell	-2,275	Closed	-$290K	–	308
2021 Q3	$290K	Sell	2,275 -7	-0.3%	-$925	0.03%	209
2021 Q2	$287K	Sell	2,282 -875	-28%	-$107K	0.03%	203
2021 Q1	$369K	Sell	3,157 -1,084	-26%	-$125K	0.04%	148
2020 Q4	$481K	Hold	4,241	–	–	0.06%	116
2020 Q3	$447K	Buy	4,241 +500	+13%	+$52.6K	0.09%	107
2020 Q2	$374K	Sell	3,741 -268	-7%	-$26.4K	0.08%	104
2020 Q1	$355K	Buy	4,009 +1,176	+42%	+$114K	0.08%	93
2019 Q4	$290K	Hold	2,833	–	–	0.05%	131
2019 Q3	$255K	Buy	2,833 +67	+2%	+$6.12K	0.05%	131
2019 Q2	$256K	Sell	2,766 -962	-26%	-$86.5K	0.05%	130
2019 Q1	$342K	Sell	3,728 -71,845	-95%	-$6.48M	0.07%	109
2018 Q4	$6.54M	Buy	+75,573	New	+$6.84M	1.39%	15

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Crescent Grove Advisors's XLV Position: Q2 2026 in Review

Crescent Grove Advisors reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 2.8% in Q2 2026, selling an estimated $6.25K and leaving 1,441 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #271.

Crescent Grove Advisors first reported a position in XLV in Q4 2018 and has held it in 28 quarters since. The position peaked at $6.54M in Q4 2018. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Crescent Grove Advisors held 1,441 shares of State Street Health Care Select Sector SPDR ETF worth $229K as of Q2 2026.
Crescent Grove Advisors sold 42 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $6.25K.
State Street Health Care Select Sector SPDR ETF made up 0.02% of Crescent Grove Advisors's portfolio in Q2 2026, its #271 holding.
Crescent Grove Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2018 and has held it in 28 quarters since.
Crescent Grove Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $6.54M in Q4 2018.
1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.